Foundation to offer universal genomic testing for glioblastoma patients DURHAM, NC / ACCESS Newswire / December 18, 2025 / Today, the Glioblastoma Foundation announced the appointment of three ...
7h
Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT in Brain Cancer
Phase 1 trial in aggressive brain cancer (Glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platformNo patient safety issues were reported The dosing marks ...
TipRanks on MSN
Shuttle Pharmaceuticals’ terminated glioblastoma trial: What investors need to know now
Shuttle Pharmaceuticals Holdings, Inc. ($SHPH) announced an update on their ongoing clinical study. Study OverviewShuttle Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results